Summary
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets; and assay panels. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. LexaGene Holdings Inc. was incorporated in 2007 and is headquartered in Beverly, Massachusetts.
History
LexaGene was founded in 2011 with the mission of revolutionizing the life sciences market. Initially focused on pathogen detection, LexaGene pivoted in 2015 to an open-access platform, creating the first and only automated sample-to-answer platform for large or small to mid-sized laboratories. Since then, LexaGene has obtained numerous awards, including a NIH SBIR grant, a STTR grant, and has been recognized by organizations such as the MassBio Accelerator and MassChallenge.
Mission
At LexaGene, we are uniting reagents, robotics, software, and services to empower life science professionals to save time, money and other resources while making groundbreaking discoveries in their life science fields with the use of our automated pathogen detection platform. Our user-friendly and open-access system will provide the highest reliability for accurate and reliable results.
Vision
LexaGene is striving to revolutionize life science research by simplifying laboratory processes, eliminating the need for tedious and time-consuming manual labor, and providing low-risk, high-accuracy detection solutions for any size laboratory. Our vision is to make our open-access platform the recognized leader in pathogen detection in research and diagnostic laboratories.
Key Team
Mr. Allan John Fabbro (VP of Corp. Devel.)
Nicole Ridgedale (Director of Corp. Marketing)
Mr. Jay Adelaar (VP of Capital Markets)
Recognition and Awards
LexaGene has obtained numerous awards, including a National Institutes of Health Small Business Innovative Research grant, a Small Business Technology Transfer grant, and has been recognized by organizations such as the MassBio Accelerator and MassChallenge.
References
